Hiv/aids And Infectious Disease public
[search 0]
More
Download the App!
show episodes
 
DFID, the Department for International Development, is the part of the UK Government that manages Britain’s aid to poor countries. We work with charities, international organisations and the governments of poor countries to find lasting solutions to the global problem of poverty. On Soundcloud you can hear the opinions of respected voices from across the international development field - on a wide range of subjects from climate change to health and education, from economic growth and trade t ...
  continue reading
 
Cystic fibrosis (CF) is one of the most prevalent global congenital disorders, affecting some 70,000 individuals worldwide and 30,000 children and adults in the United States. While clinical efforts are expanding worldwide to improve diagnostic testing and treatment approaches for this progressive lung disease, targeted therapies for CF against any specific mutation remain elusive. The Cystic Fibrosis in Focus series gathers the latest information from leading medical experts devoted to adva ...
  continue reading
 
Loading …
show series
 
Host: Paul Doghramji, MD Guest: Gregory S. Sawicki, MD, MPH Even though there currently isn’t a cure for cystic fibrosis, there may finally be hope on the horizon for the more than 70,000 people around the world who are living with this debilitating disease. Joining Dr. Paul Dogramji to talk about the emerging treatment options for cystic fibrosis …
  continue reading
 
Akuja de Garang is the project leader of the UK aid-funded programme Girls' Education South Sudan.On her way to Buckingham Palace to receive an MBE for her work, she came to speak to DFID about her life as a refugee and how she returned to South Sudan, where she was born, as an adult to help girls go to school.Listen to Akuja's inspirational story …
  continue reading
 
Today, differing health conditions are changing the requirements of the global response, like shifting focus to preventing and responding to non-communicable diseases like cancer and diabetes, which are responsible for every 7 out of 10 deaths globally today.WHO’s immense responsibility in meeting modern health challenges across the world requires …
  continue reading
 
Drawing on expertise working in over 50 countries, Dr David Nabarro discusses tackling infectious diseases like malaria, TB, HIV/AIDs and neglected tropical diseases. He also discusses facing global health security threats facing the world today, like anti-microbial resistance.By DFID
  continue reading
 
Candidate for WHO Director General Dr David Nabarro draws on over 40 years of experience and expertise to explain the importance of coordinated and quick responses by the WHO in humanitarian crises and emergencies. He discusses how communities, especially children are impacted by food shortages, and what’s needed to provide a concerted global respo…
  continue reading
 
16-year-old twins Hope and Leah escaped FGM with minutes to spare. Listen to them tell their story and find out why they want to fight for girls' rights.Background: UK Aid works through partners to support a collective abandonment of the FGM, encouraging whole communities to say no to FGM together. We are backing the Africa-led movement to end FGM,…
  continue reading
 
Stefan Dercon DFID's Chief Economist introduces DFID's first Economic Development Strategy.DFID’s Economic Development Strategy sets out how Britain will establish new trade, investment and economic links and end global poverty.https://www.gov.uk/government/publications/dfids-economic-development-strategy-2017…
  continue reading
 
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Flume PA, VanDevanter DR, Morgan EE, Dudley MN, Loutit JS, Bell SC, Kerem E, Fischer R, Smyth AR, Aaron SD, Conrad D, Geller DE,Elborn JS. J…
  continue reading
 
Microbial colonization and lung function in adolescents with cystic fibrosis. Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D. J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5. Abstract With…
  continue reading
 
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA,Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC…
  continue reading
 
Loading …

Quick Reference Guide